blinatumomab,ponatinib
amgen,otsuka,astellas,incyte,takeda
['ponatinib', 'ph+ all', 'blinatumomab']
congress|#ash22|poster daniel nguyen from the university of texas health science center presented the phase ii study results on the sequential combination use of mini-hyper-cvd, blinatumomab, and ponatinib in pts with ph+ all, which proved highly effective and was well-tolerated 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm